AM, F., M, B., FM, S., T, L., S, J., P, W., . . . JD, K. (2026). A Urinary Three-Metabolite Signature Enables Noninvasive Identification of Patients with High-Risk Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 32(14), 2968. https://doi.org/10.1158/1078-0432.CCR-25-4260
Chicago Style (17th ed.) CitationAM, Funk, et al. "A Urinary Three-Metabolite Signature Enables Noninvasive Identification of Patients with High-Risk Ovarian Cancer." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 32, no. 14 (2026): 2968. https://doi.org/10.1158/1078-0432.CCR-25-4260.
MLA (9th ed.) CitationAM, Funk, et al. "A Urinary Three-Metabolite Signature Enables Noninvasive Identification of Patients with High-Risk Ovarian Cancer." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 32, no. 14, 2026, p. 2968, https://doi.org/10.1158/1078-0432.CCR-25-4260.